117 related articles for article (PubMed ID: 1716713)
1. Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy.
Remuzzi A; Perticucci E; Ruggenenti P; Mosconi L; Limonta M; Remuzzi G
Kidney Int; 1991 Jun; 39(6):1267-73. PubMed ID: 1716713
[TBL] [Abstract][Full Text] [Related]
2. ACE inhibition and ANG II receptor blockade improve glomerular size-selectivity in IgA nephropathy.
Remuzzi A; Perico N; Sangalli F; Vendramin G; Moriggi M; Ruggenenti P; Remuzzi G
Am J Physiol; 1999 Mar; 276(3):F457-66. PubMed ID: 10070170
[TBL] [Abstract][Full Text] [Related]
3. Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy.
Morelli E; Loon N; Meyer T; Peters W; Myers BD
Diabetes; 1990 Jan; 39(1):76-82. PubMed ID: 1698674
[TBL] [Abstract][Full Text] [Related]
4. ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome.
Ruggenenti P; Mosconi L; Vendramin G; Moriggi M; Remuzzi A; Sangalli F; Remuzzi G
Am J Kidney Dis; 2000 Mar; 35(3):381-91. PubMed ID: 10692263
[TBL] [Abstract][Full Text] [Related]
5. Converting enzyme inhibition and glomerular size selectivity in diabetic nephropathy.
Meyer TW; Morelli E; Loon N; Peters W; Myers BD
J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S64-8. PubMed ID: 16989068
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme inhibition ameliorates the defect in glomerular size selectivity in hyponatremic hypertensive syndrome.
Remuzzi A; Schieppati A; Battaglia C; Remuzzi G
Am J Kidney Dis; 1989 Sep; 14(3):170-7. PubMed ID: 2476029
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat.
Remuzzi A; Puntorieri S; Battaglia C; Bertani T; Remuzzi G
J Clin Invest; 1990 Feb; 85(2):541-9. PubMed ID: 1688888
[TBL] [Abstract][Full Text] [Related]
8. Glomerular size-selective dysfunction in NIDDM is not ameliorated by ACE inhibition or by calcium channel blockade.
Ruggenenti P; Mosconi L; Sangalli F; Casiraghi F; Gambara V; Remuzzi G; Remuzzi A
Kidney Int; 1999 Mar; 55(3):984-94. PubMed ID: 10027935
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme inhibition does not correct early defects in renal and vascular permeability in diabetes mellitus.
Zietse R; Derkx FH; Weimar W; Schalekamp MA
Clin Sci (Lond); 1998 Feb; 94(2):165-73. PubMed ID: 9536925
[TBL] [Abstract][Full Text] [Related]
10. Low-dose sirolimus combined with angiotensin-converting enzyme inhibitor and statin stabilizes renal function and reduces glomerular proliferation in poor prognosis IgA nephropathy.
Cruzado JM; Poveda R; Ibernón M; Díaz M; Fulladosa X; Carrera M; Torras J; Bestard O; Navarro I; Ballarín J; Romero R; Grinyó JM
Nephrol Dial Transplant; 2011 Nov; 26(11):3596-602. PubMed ID: 21393611
[TBL] [Abstract][Full Text] [Related]
11. MK-591 acutely restores glomerular size selectivity and reduces proteinuria in human glomerulonephritis.
Guasch A; Zayas CF; Badr KF
Kidney Int; 1999 Jul; 56(1):261-7. PubMed ID: 10411701
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of the antiproteinuric effect of cyclosporine in membranous nephropathy.
Ambalavanan S; Fauvel JP; Sibley RK; Myers BD
J Am Soc Nephrol; 1996 Feb; 7(2):290-8. PubMed ID: 8785399
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of antihypertensives on proteinuria: angiotensin-converting enzyme inhibitor versus alpha 1-antagonist.
Rosenberg ME; Hostetter TH
Am J Kidney Dis; 1991 Oct; 18(4):472-82. PubMed ID: 1656730
[TBL] [Abstract][Full Text] [Related]
14. Proteinuria and functional characteristics of the glomerular barrier in diabetic nephropathy.
Carrie BJ; Myers BD
Kidney Int; 1980 May; 17(5):669-76. PubMed ID: 6157049
[TBL] [Abstract][Full Text] [Related]
15. ACEI/ATRA therapy decreases proteinuria by improving glomerular permselectivity in IgA nephritis.
Woo KT; Lau YK; Wong KS; Chiang GS
Kidney Int; 2000 Dec; 58(6):2485-91. PubMed ID: 11115082
[TBL] [Abstract][Full Text] [Related]
16. The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy.
Song JH; Lee SW; Suh JH; Kim ES; Hong SB; Kim KA; Kim MJ
Clin Nephrol; 2003 Nov; 60(5):318-26. PubMed ID: 14640237
[TBL] [Abstract][Full Text] [Related]
17. Effects of angiotensin II blockade on nitric oxide blood levels in IgA nephropathy.
Roccatello D; Mengozzi G; Gigliola G; Rossi D; Mosso R; Cacace G; Polloni R; Cesano G; Picciotto G; Paradisi L; Bancale E; Piccoli G; Sena LM
Nephrol Dial Transplant; 2000 Jul; 15(7):988-93. PubMed ID: 10862636
[TBL] [Abstract][Full Text] [Related]
18. Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis. Short-term observation.
Tylicki L; Rutkowski P; Renke M; Rutkowski B
Am J Nephrol; 2002; 22(4):356-62. PubMed ID: 12169868
[TBL] [Abstract][Full Text] [Related]
19. Glomerular permselectivity in early stages of overt diabetic nephropathy.
Andersen S; Blouch K; Bialek J; Deckert M; Parving HH; Myers BD
Kidney Int; 2000 Nov; 58(5):2129-37. PubMed ID: 11044234
[TBL] [Abstract][Full Text] [Related]
20. Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR.
Zhou X; Matavelli LC; Ono H; Frohlich ED
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F871-9. PubMed ID: 15900021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
